[A. B. A. El-Gazzar, M. M. El-Enany and M. N. Mahmoud, Synthesis, Analgesic, anti-inflammatory and antimicrobial activity of some novel pyrimido[4,5-d]quinolin-4-ones, Bioorg. Med. Chem. 16 (2008) 3261-3273; DOI: 10.1016/j.bmc.2007.12.012.10.1016/j.bmc.2007.12.012]Search in Google Scholar
[D. H. Boschelli, Z. Wu, S. R. Klutchko, H. D. Showalter, J. M. Hamby, G. H. Lu, T. C. Major, T. K. Dahring, B. Batley, R. L. Panek, J. Keiser, B. G. Hartl, A. J. Kraker, W. D. Klohs, B. J. Roberts, S. Patmore, W. L. Elliott, R. Steinkampf, L. A. Bradford, H. Hallak and A. M. Doherty, Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent selective platelet-derived growth factor receptor tyrosine kinase inhibitors, J. Med. Chem. 41 (1998) 4365-4377; DOI: 10.1021/jm980398y 50022-2623(98)00398-7.10.1021/jm980398y]Search in Google Scholar
[S. R. Natarajan, D. D. Wisnoski, J. E. Thompson, E. A. O'Neill and S. J. O'Keefe, p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones, Bioorg. Med. Chem. Lett. 16 (2006) 4400-4404; DOI: 10.1016/j.bmcl. 2006.05.045.]Search in Google Scholar
[C. B. Vu, G. P. Luke, N. Kawahata, W. C. Shakespeare, Y. Wang, R. Sundara-Moorthi, C. A. Metcalf, T. P. Keenan, S. Pradeepan, E. Corpuz, T. Merry, R. S. Bohacek, D. C. Dalgarno, S. S. Narula, M. R. van Schravendijk, M. K. Ram, S. Adams, S. Liou, J. A. Keats, S. M. Violette, W. Guan, M. Weigele and T. K. Sawyer, Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of src tyrosine kinase as novel antiresorptive agents, Bioorg. Med. Chem. Lett. 13 (2003) 3071-3074; DOI: 10.1016/S0960-894X(03)00649-8.10.1016/S0960-894X(03)00649-8]Search in Google Scholar
[A. J. Kraker, B. G. Hartl, A. M. Amar, M. R. Barvian, H. D. Hollis Showalter and C. W. Moore, Biochemical and cellular effect of c-Src kinase-selective pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors, Biochem. Pharmacol. 60 (2000) 885-898.10.1016/S0006-2952(00)00405-6]Search in Google Scholar
[M. Barvian, R. J. Booth, J. Quin III., J. T. Repine, D. J. Sheehan, P. L. Toogood, S. N. Vanderwel and H. Zhou, 2-(Pyridin-2-yl-amino)-pyrido[2,3-d]pyrimidin-7-ones, PCT. Int. Appl. (2007), (C07D401/14; A61K31/444) WO 7208489.]Search in Google Scholar
[H. B. Arzeno, J. J. Chen, J. P. Dunn, D. M. Goldstein and J. A. Lim, Preparation of 7-oxopyridopyrimidines as P38 MAP kinase inhibitors, PCT. Int. Appl. (2002), WO 200218379.]Search in Google Scholar
[R. J. Booth, A. Chatterjee and T. C. Malone, Pyridopyrimidinone derivatives for treatment of neurodegenerative disease, PCT. Int. Appl. (2001), WO 2001055148.]Search in Google Scholar
[S. Tu, J. Zhang, X. Zhu, J. Xu, Y. Zhang, Q. Wang, R. Jia, B. Jiang and J. Zhang, New potential inhibitors of cyclin-dependent kinase: Design and synthesis of pyrido[2,3-d]pyrimidine derivatives under microwave irradiation, Bioorg. Med. Chem. Lett. 16 (2006) 3578-3581; DOI: 10.1016/j. bmcl.2006.03.084.]Search in Google Scholar
[M. Hájek, N. Matulová, I. Votruba, A. Holý and E. Tlouš'tova, Inhibition of human, telomerase by diphosphates of acyclic nucleoside phosphonates, Biochem. Pharmacol. 70 (2005) 894-900; DOI: 10.1016/j.bcp.2005.06.07.]Search in Google Scholar
[J. J. Chen, J. P. Dunn, D. M. Goldstein and C. M. Stahl, Preparation of 2,6-disubstituted 7-oxopyrido[2,3-d]pyrimidines for treating P38 mediated disorders, PCT. Int. Appl. (2002) WO 2002064594.]Search in Google Scholar
[S. R. Kanth, G. V. Reddy, K. H. Kishore, P. S. Rao, B. Narsaiah and U. S. N. Murthy, Convenient synthesis of novel 4-substituted amino-5-trifluoromethyl-2,7-disubstituted pyrido[2,3-d] pyrimidines and their antibacterial activity, Eur. J. Med. Chem. 41 (2006) 1011-1016; DOI: 10.1016/j.ejmech. 2006.03.028.]Search in Google Scholar
[V. Darias, S. S. Abdallah, M. L. Tello, L. D. Delgado and S. Vega, NSAI activity study of 4-phenyl-2-thioxo-benzo[4,5]thieno[2,3-d]pyrimidines derivatives, Arch. Pharm. 327 (1994) 779-383; DOI: 10.1002/ardp. 19943271205.]Search in Google Scholar
[L. Cordeu, E. Cubedo, E. Bandres, A. Rebollo, X. Saenz, H. M. Chozes, V. Dominquez, M. Echeverria, B. Mendivil, C. Sanmartin, J. A. Palop, M. Font and J. Garcia-Foncillas, Biological profile of new apoptotic agents based on 2,4-pyrido[2,3-d]-pyrimidine derivatives, Bioorg. Med. Chem. 15 (2007) 1659-1669; DOI: 10.1016/j.bmc.2006.12.010.10.1016/j.bmc.2006.12.01017204425]Search in Google Scholar
[M. Zink, H. Lanig and R. Troschütz, Structural variations of piritrexim, a lipophilic inhibitor of human dihydrofolate reductase: synthesis, antitumor activity and molecular modeling investigations, Eur. J. Med. Chem. 39 (2004) 1079-1088; DOI: 10.1016/j.ejmech.2004.09.001.10.1016/j.ejmech.2004.09.00115571870]Search in Google Scholar
[R. A. Newberry and B. J. Bushell, Thiazole derivatives U.S. 3, 979, 402 (Cl.260-302R; Co7 D227122). 07 Sep. (1976), Brit. Appl. 748, 870, 27 Feb. (1974); ref. Chem. Abstr. 86 (1977) 29795z.]Search in Google Scholar
[M. Yu. Gavrilov, L. G. Mardanova, V. E. Kolla and M. E. Konshin, Synthesis and anti-inflammatory and analgesic activities of 2-arylamino-5,6,7,8-tetrahydroquinoline-3-carboxamides, J. Pharm. Chem. 22 (1988) 554-556; DOI: 10.1007/BF00763528.10.1007/BF00763528]Search in Google Scholar
[A. B. A. El-Gazzar, A. M. Gaafar, H. N. Hafez and A. M. Abdel-Fattah, Regioselective synthesis and reactions of polynuclear heterocyclic derived from pyrido[2,3-d]pyrimidines, with new ring system, Phosphorus, Sulfur, Silicon 182 (2007) 369-403; DOI: 10.1080/10426500600919967.10.1080/10426500600919967]Search in Google Scholar
[Guide for the Care and Use of Animals (Eds. E. D. Olfert, B. M. Cross and A. A. McWilliam), 2nd ed, Vol. I, Canadian Council on Animal Care, Ottawa 1993, p. 211.]Search in Google Scholar
[C. A. Winter, E. A. Risley and G. W. Nuss, Carragenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs, Proc. Soc. Exp. Biol. Med. 111 (1962) 544-547.10.3181/00379727-111-2784914001233]Search in Google Scholar
[O. O. Adeyemi, O. S. Okpo and O. J. Okpaka. The analgesic effect of the methanolic extract of acanthus montanus, Ethnopharmacology 90 (2004) 45-48; DOI: 10.1016/j.jep.2003.09.021.10.1016/j.jep.2003.09.02114698507]Search in Google Scholar
[V. Cioli, S. Putzolu, V. Rossi, S. P. Barrcellona and C. Corradino, The role of direct tissue contact in the production of gastro-intestinal ulcers by anti-inflammatory drugs in rats, Toxicol. Appl. Pharmacol. 50 (1979) 283-289.10.1016/0041-008X(79)90153-4]Search in Google Scholar